Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis
- PMID: 34845757
- DOI: 10.1111/cen.14646
Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis
Abstract
Objectives: The risk of congenital anomalies following in utero exposure to thionamide antithyroid drugs (ATDs) is unresolved. Observational studies are contradictory and existing meta-analyses predate and preclude more recent studies. We undertook an updated meta-analysis of congenital anomaly risk in women exposed to carbimazole or methimazole (CMZ/MMI), propylthiouracil (PTU), or untreated hyperthyroidism in pregnancy.
Methods: We searched Medline, Embase, and the Cochrane database for articles published up till August 2021. We pooled separate crude and adjusted risk estimates using random effects models and subgroup analyses to address heterogeneity.
Results: We identified 16 cohort studies comprising 5957, 15,785, and 15,666 exposures to CMZ/MMI, PTU, and untreated hyperthyroidism, respectively. Compared to nondisease controls, adjusted risk ratio (RR) and 95% confidence intervals (95% CIs) for congenital anomalies was increased for CMZ/MMI (RR, 1.28; 95% CI, 1.06-1.54) and PTU (RR, 1.16; 95% CI, 1.08-1.25). Crude risk for CMZ/MMI was increased relative to PTU (RR, 1.20; 95% CI, 1.01-1.43). Increased risk was also seen with exposure to both CMZ/MMI and PTU, that is, women who switched ATDs in pregnancy (RR, 1.51; 95% CI, 1.14-1.99). However, the timing of ATD switch was highly variable and included prepregnancy switches in some studies. The excess number of anomalies per 1000 live births was 17.2 for patients exposed to CMZ/MMI, 9.8, for PTU exposure, and 31.4 for exposure to both CMZ/MMI and PTU. Risk in the untreated group did not differ from control or ATD groups. The untreated group was however highly heterogeneous in terms of thyroid status. Subgroup analysis showed more positive associations in studies with >500 exposures and up to 1-year follow-up.
Conclusions: ATD therapy carries a small risk of congenital anomalies which is higher for CMZ/MMI than for PTU and does not appear to be reduced by switching ATDs in pregnancy. Due to key limitations in the available data, further studies will be required to clarify the risks associated with untreated hyperthyroidism and with switching ATDs in pregnancy.
Keywords: carbimazole; hyperthyroidism congenital anomalies; methimazole; pregnancy antithyroid drugs; propylthiouracil.
© 2021 The Authors. Clinical Endocrinology published by John Wiley & Sons Ltd.
Similar articles
-
Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.J Clin Endocrinol Metab. 2013 Nov;98(11):4373-81. doi: 10.1210/jc.2013-2831. Epub 2013 Oct 22. J Clin Endocrinol Metab. 2013. PMID: 24151287
-
Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies.PLoS One. 2015 May 14;10(5):e0126610. doi: 10.1371/journal.pone.0126610. eCollection 2015. PLoS One. 2015. PMID: 25974033 Free PMC article.
-
Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations.Br J Clin Pharmacol. 2021 Oct;87(10):3890-3900. doi: 10.1111/bcp.14805. Epub 2021 Mar 30. Br J Clin Pharmacol. 2021. PMID: 33783857 Free PMC article.
-
Teratogen update: Antithyroid medications.Birth Defects Res. 2020 Sep;112(15):1150-1170. doi: 10.1002/bdr2.1771. Epub 2020 Aug 1. Birth Defects Res. 2020. PMID: 32738035 Review.
-
Safety of antithyroid drugs in pregnancy: update and therapy implications.Expert Opin Drug Saf. 2020 May;19(5):565-576. doi: 10.1080/14740338.2020.1748007. Epub 2020 Apr 1. Expert Opin Drug Saf. 2020. PMID: 32223355 Review.
Cited by
-
Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis.PLoS One. 2023 May 19;18(5):e0286097. doi: 10.1371/journal.pone.0286097. eCollection 2023. PLoS One. 2023. PMID: 37205692 Free PMC article.
-
Structural congenital anomalies in resource limited setting, 2023: A systematic review and meta-analysis.PLoS One. 2023 Oct 13;18(10):e0291875. doi: 10.1371/journal.pone.0291875. eCollection 2023. PLoS One. 2023. PMID: 37831686 Free PMC article.
-
Effects of Methimazole vs Propylthiouracil in Newborns: A Comparative Review.Cureus. 2023 Jul 7;15(7):e41505. doi: 10.7759/cureus.41505. eCollection 2023 Jul. Cureus. 2023. PMID: 37551246 Free PMC article. Review.
-
Preconception Management of Hyperthyroidism and Thyroid Status in Subsequent Pregnancy: A Population-Based Cohort Study.J Clin Endocrinol Metab. 2023 Oct 18;108(11):2886-2897. doi: 10.1210/clinem/dgad276. J Clin Endocrinol Metab. 2023. PMID: 37200150 Free PMC article.
-
Radioiodine Therapy of Graves' Disease in Women with Childbearing Potential and the Pre-Conceptional Counseling About Antithyroid Drugs.J Clin Med. 2025 Feb 28;14(5):1667. doi: 10.3390/jcm14051667. J Clin Med. 2025. PMID: 40095630 Free PMC article. Review.
References
REFERENCES
-
- Andersen SL, Olsen J, Carlé A, Laurberg P. Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a Danish population-based study. J Clin Endocrinol Metab. 2015;100(3):1164-1171.
-
- Andersen SL, Olsen J, Wu CS, Laurberg P. Spontaneous abortion, stillbirth and hyperthyroidism: a danish population-based study. Eur Thyroid J. 2014;3(3):164-172.
-
- Okosieme OE, Lazarus JH. Important considerations in the management of Graves' disease in pregnant women. Expert Rev Clin Immunol. 2015;11(8):947-957.
-
- Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994;84(6):946-949.
-
- Burch HB, Cooper DS. Anniversary review: antithyroid drug therapy: 70 years later. Eur J Endocrinol. 2018;179(5):R261-R274.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials